Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/VAXXINITY-INC-129226100/news/Vaxxinity-Inc-gibt-bekannt-dass-die-ersten-Probanden-in-der-klinischen-Phase-1-Studie-mit-VXX-401-43300111/?utm_source=whatsapp&utm_medium=social&utm_campaign=share